Back

Treatment with sacubitril/valsartan and improvement of ventricular-arterial coupling in heart failure with reduced ejection fraction

25 August 2023 (09:15 - 09:50)
Organised by: Logo
Congress Presentation Part of: It is all about heart failure Systolic and Diastolic Function ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Tina Stegmann

University hospital Leipzig AoR, Leipzig (Germany)

6 More presentations in this session

Presentation thumbnail
Prognosis of diastolic dysfunction in patients with preserved LVEF. Value of left atrial strain.
Mr I. Rodriguez-Sanchez (Galdakao, ES)
Abstract Slides Video
Presentation thumbnail
Postsystolic shortening by speckle tracking echocardiography predicts cardiovascular events and death in the general population
Mrs N. Lindhardt (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Prognostic value of three-dimensional regurgitant orifice determination in functional mitral regurgitation
Doctor J. Diz Diaz (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics and outcomes of left ventricular thrombus patients with mildly reduced and preserved left ventricular ejection fraction
Doctor F. Goh (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Right ventricular pulmonary arterial coupling in patients with implanted left ventricular assist devices
Doctor M. Stapor (Krakow, PL)
Abstract Slides Video

Access the full session

Session thumbnail
It is all about heart failure

The Event

Event poster

ESC Congress 2023

25 August 2023 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Short-term effects on sacubitril/valsartan therapy on right ventricle work and mechanics in patients with heart failure and reduced ejection fraction
thumbnail
Congress Presentation
Real world data using sacubitril/valsartan in CKD stage 4 and 5 is associated with improved ejection fraction and may have renoprotective effects.
thumbnail
Congress Presentation
The positive effect of sacubitril/valsartan therapy on QRS width and QTC interval on electrocardiogram in heart failure patients with reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources